← SynDRA
LANABECESTAT
SynDRA canonical compound SYN0039173 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | BACE1 |
|---|
| Mechanism of action | beta secretase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- BACE1 INHIBITOR
- Beta-secretase 1 inhibitor
- beta secretase inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- AZD-3293
- AZD3293
- LANABECESTAT (AZD3293)
- LY-3314814
- LY3314814
- CHEMBL2152914
- SCHEMBL9948518
- SCHEMBL9948271
- SCHEMBL18562845
- BDBM50393099
- UNII-X8SPJ492VF
- X8SPJ492VF
- Lanabecestat [USAN]
- Lanabecestat (USAN)
- SCHEMBL9947930
- GTPL7789
- SCHEMBL9947926
- CHEMBL3261045
- SCHEMBL10249890
- CHEMBL3989948
- CHEMBL3349234
- BDBM41542
- BDBM41537
- MolPort-044-560-403
- BDBM136733
- EX-A1471
- s8193
- ZINC95576075
- BDBM50012629
- US8865911, 20a Isomer 1
- CS-7494
- Lanabecestat(AZD3293,LY-3314814)
- HY-100740
- LY 3314814
- D10946
- US8865911, 122
- US8865911, 114
- 4-methoxy-5'-methyl-6'-(5-(prop-1-yn-1-yl)pyridin-3-yl)-3'H-dispiro(cyclohexane
Look up LANABECESTAT in the interactive SynDRA portal →